Skip to main content
. 2016 Aug 5;15:135. doi: 10.1186/s12934-016-0533-4

Fig. 3.

Fig. 3

HPLC-PDA analysis of a in vitro hydroxylation reaction mixture and b whole cells bioconversion of naringenin. (i) control reaction of naringenin using E. coli BL21 (DE3); (ii) hydroxylation of naringenin with CYP450 BM3, (iii) M13 and (iv) M15, respectively